Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition
9 May 2026 – 14 May 2026 · Cape Town, South Africa
566-03-008 ISMRM Abstract

Radiomics Model Leveraging AI-Extracted ADC Map Features Predicts Biochemical Recurrence in Advanced Prostate Cancer

Primary: Body - Prostate
Secondary: Analysis Methods - Classification and Prediction
566-03-008 · Radiomics Potpourri · Wednesday, 13 May, 1:40 PM–2:35 PM · Digital Posters Row G
Keywords: Survival risk stratification Biochemical recurrence Radiomics analysis Automated diagnosis Prostate adenocarcinoma
Accepted
Huihui Wang 1, Kexin Wang1
1Radiology Department, Peking University First Hospital, Beijing, China
Presenting Author: Huihui Wang

Synopsis

Motivation:
Goals:
Approach:
Results:
Full abstract & presentation

The full text, figures, and any recorded presentation for this abstract are not shown here. Log in if you are a member or registered attendee with access.

Full abstracts, figures, and presentations for Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition are available to registered attendees. This content becomes freely available to the public roughly two years after the meeting.

To request or purchase access, contact the ISMRM Central Office at info@ismrm.org.

Log in

References

1. Filho AM, Laversanne M, Ferlay J, Colombet M, Piñeros M, Znaor A, et al. The GLOBOCAN 2022 cancer estimates: Data sources, methods, and a snapshot of the cancer burden worldwide. Int J Cancer. 2025;156(7):1336-46.
2. Van den Broeck T, van den Bergh RCN, Briers E, Cornford P, Cumberbatch M, Tilki D, et al. Biochemical Recurrence in Prostate Cancer: The European Association of Urology Prostate Cancer Guidelines Panel Recommendations. Eur Urol Focus. 2020;6(2):231-4.
3. Van den Broeck T, van den Bergh RCN, Arfi N, Gross T, Moris L, Briers E, et al. Prognostic Value of Biochemical Recurrence Following Treatment with Curative Intent for Prostate Cancer: A Systematic Review. Eur Urol. 2019;75(6):967-87.
4. Freedland SJ, Humphreys EB, Mangold LA, Eisenberger M, Dorey FJ, Walsh PC, et al. Death in patients with recurrent prostate cancer after radical prostatectomy: prostate-specific antigen doubling time subgroups and their associated contributions to all-cause mortality. J Clin Oncol. 2007;25(13):1765-71.
5. Cooperberg MR, Pasta DJ, Elkin EP, Litwin MS, Latini DM, Du Chane J, et al. The University of California, San Francisco Cancer of the Prostate Risk Assessment score: a straightforward and reliable preoperative predictor of disease recurrence after radical prostatectomy. J Urol. 2005;173(6):1938-42.
6. Tilki D, Mandel P, Schlomm T, Chun FK, Tennstedt P, Pehrke D, et al. External validation of the CAPRA-S score to predict biochemical recurrence, metastasis and mortality after radical prostatectomy in a European cohort. J Urol. 2015;193(6):1970-5.
7. Panebianco V, Villeirs G, Weinreb JC, Turkbey BI, Margolis DJ, Richenberg J, et al. Prostate Magnetic Resonance Imaging for Local Recurrence Reporting (PI-RR): International Consensus -based Guidelines on Multiparametric Magnetic Resonance Imaging for Prostate Cancer Recurrence after Radiation Therapy and Radical Prostatectomy. Eur Urol Oncol. 2021;4(6):868-76.
8. Zhong QZ, Long LH, Liu A, Li CM, Xiu X, Hou XY, et al. Radiomics of Multiparametric MRI to Predict Biochemical Recurrence of Localized Prostate Cancer After Radiation Therapy. Front Oncol. 2020;10:731.
9. Muglia VF, Laschena L, Pecoraro M, de Lion Gouvea G, Colli LM, Panebianco V. Imaging assessment of prostate cancer recurrence: advances in detection of local and systemic relapse. Abdom Radiol (NY). 2025;50(2):807-26.
10. Salimi M, Vadipour P, Houshi S, Yazdanpanah F, Seifi S. MRI-based radiomics for prediction of biochemical recurrence in prostate cancer: a systematic review and meta-analysis. Abdom Radiol (NY). 2025:Epub ahead of print

Cite this abstract

http://echo.ismrm.org/p/ISMRM2026/566-03-008